Zyprexa News
Zyprexa Makers Withdraw Advice Leaflet
- February 17, 2006
The Medicines and Healthcare products Regulatory Agency (the UK's equivalent to the FDA) has reprimanded Eli Lilly, the makers of Zyprexa, for producing a leaflet that failed to mention the side effects of its drugs.
The U.K. version of the FDA found that the leaflets were misleading patients by not showing that the company had written and paid for the leaflet. Also, it was criticized for not highlighting the risks of using schizophrenia medication such as Zyprexa.
Zyprexa is an atypical antipsychotic drug, which has been known to cause diabetes and even death. Last year, this drug generated $4.2 billion in sales.
Ely Lilly responded to these accusations by saying that their failure to mention that it was a sponsored leaflet was "an oversight." Ely Lilly then withdrew the leaflet in May 2005 as soon as the medicines regulatory agency contacted them. The leaflet, however, had already been in circulation since September of 2003.
In addition to the leaflet having to be withdrawn, the drug company must now make a corrective statement on their website for Diabetes UK. On this website, Ely Lilly had made the statement that the information in the leaflet in question was accurate. They also said that the side effect information was complete at the time of publication.
The only regret from the Medicines and Healthcare products Regulatory Agency in the U.K. is that they did not act sooner. They believed that they were acting in a "gray area" of legislation. Now, though, the agency will act quicker to ensure remedial action will always be taken.
For more information on Zyprexa, please contact us to confer with a Zyprexa attorney.
Homepage • Lawsuit • Alternatives • Heart Attack • Injuries • Warning • Withdrawal • Risk • Diabetes • Side Effects • Reports • Information • Zyprexa and Women • Resources • Safety • News • Lawsuit Evaluation • Site Map
Whether
or not Zyprexa and similar atypical antipsychotic drugs are linked to diabetes
is a question that will be answered in the Zyprexa lawsuits that have been
filed. Patients have reported deadly instances of Zyprexa side effects. There
are 288 reported cases of Zyprexa diabetes cases, including 23 deaths.
Zyprexa maker Eli Lilly has enjoyed large success with Zyprexa, with the drug
currently the world’s top selling schizophrenia medication. The Zyprexa
side effects causing Zyprexa lawsuits may begin slowing the company’s
current financial success. For more information on